All Stories

  1. Health education and empowerment in adult patients with haemophilia

    Article • Expert Review of Hematology, August 2019, Taylor & Francis

    Dr. E. Carlos Rodriguez-Merchan, Dr MARIA TERESA ALVAREZ ROMAN, Dr Victor Jimenez-Yuste

  2. A randomized trial of safety, pharmacokinetics and pharmacodynamics of concizumab in people with hemophilia A

    Article • Journal of Thrombosis and Haemostasis, September 2018, Wiley

    Professor Paul Knoebl, Dr Victor Jimenez-Yuste

  3. Recommendations on multidisciplinary management of elective surgery in people with haemophilia

    Article • Haemophilia, June 2018, Wiley

    Dr Victor Jimenez-Yuste, Dr. E. Carlos Rodriguez-Merchan

  4. Head trauma in the haemophilic child and management in a paediatric emergency department: Descriptive study

    Article • Haemophilia, June 2018, Wiley

    Dr Victor Jimenez-Yuste

  5. Immune thrombocytopenia - in defence of the platelet count. Response to Hill

    Article • British Journal of Haematology, May 2017, Wiley

    Dr Nora Butta, Dr Victor Jimenez-Yuste, IHOSVANY FERNANDEZ BELLO

  6. Outcome measures for adult and pediatric hemophilia patients with inhibitors

    Article • European Journal Of Haematology, April 2017, Wiley

    Massimo Morfini, Dr Victor Jimenez-Yuste

  7. Long-term outcome of haemophilia A patients after successful immune tolerance induction therapy using a single plasma-derived FVIII/VWF product: the long-term ITI study

    Article • Haemophilia, June 2016, Wiley

    Dr Victor Jimenez-Yuste

  8. Clinical overview of Fanhdi/Alphanate (plasma-derived, VWF-containing FVIII concentrate) in immune tolerance induction in haemophilia A patients with inhibitors

    Article • Haemophilia, November 2015, Wiley

    Dr Victor Jimenez-Yuste

  9. Arthroscopic debridement for ankle haemophilic arthropathy

    Article • Blood Coagulation & Fibrinolysis, April 2015, Wolters Kluwer Health

    Dr Victor Jimenez-Yuste

  10. The pharmacokinetics of a B-domain truncated recombinant factor VIII, turoctocog alfa (NovoEight® ), in patients with hemophilia A

    Article • Journal of Thrombosis and Haemostasis, February 2015, Wiley

    Dr Victor Jimenez-Yuste

  11. Adherence to prophylaxis and quality of life in children and adolescents with severe haemophilia A

    Article • Haemophilia, February 2015, Wiley

    Dr Victor Jimenez-Yuste

  12. Light-chain amyloidosis presenting as a change in bleeding phenotype in a patient with mild haemophilia A

    Article • Haemophilia, November 2014, Wiley

    Dr Victor Jimenez-Yuste

  13. Radiosynovectomy in haemophilia: Long-term results of 500 procedures performed in a 38-year period

    Article • Thrombosis Research, November 2014, Elsevier

    Dr Victor Jimenez-Yuste

  14. Adult haemophilia A patients with inhibitors: successful immune tolerance induction with a single FVIII / VWF product

    Article • Haemophilia, October 2014, Wiley

    Dr Victor Jimenez-Yuste

  15. Hematological Concepts and Hematological Perioperative Treatment

    Article • October 2014, Springer Science + Business Media

    Dr Victor Jimenez-Yuste

  16. The Analgesic Efficacy of a COX-2 Inhibitor (Oral Celecoxib) in Adult Hemophilic Patients and Intense Joint Pain Secondary to Advanced Hemophilic Arthropathy

    Article • October 2014, Springer Science + Business Media

    Dr Victor Jimenez-Yuste

  17. Switching treatments in haemophilia: is there a risk of inhibitor development?

    Article • European Journal Of Haematology, September 2014, Wiley

    Dr Victor Jimenez-Yuste, Dr. Eduardo Remor

  18. Effect of thrombopoietin-receptor agonists on a proliferation-inducing ligand (APRIL) plasma levels in patients with immune thrombocytopaenia

    Article • British Journal of Clinical Pharmacology, August 2014, Wiley

    Dr Victor Jimenez-Yuste, Dr Nora Butta

  19. Managing Haemophilia for Life: 4th Haemophilia Global Summit

    Article • Haemophilia, June 2014, Wiley

    Dr Victor Jimenez-Yuste

  20. Joint disease, the hallmark of haemophilia: What issues and challenges remain despite the development of effective therapies?

    Article • Thrombosis Research, June 2014, Elsevier

    Dr Victor Jimenez-Yuste, Dr. Eduardo Remor

  21. Is radiosynovectomy (RS) effective for joints damaged by haemophilia with articular degeneration in simple radiography (ADSR)?

    Article • Thrombosis Research, May 2014, Elsevier

    Dr Victor Jimenez-Yuste, Professor E. Carlos RODRIGUEZ-MERCHAN

  22. Efficacy of celecoxib in the treatment of joint pain caused by advanced haemophilic arthropathy in adult patients with haemophilia A

    Article • Haemophilia, March 2014, Wiley

    Dr Victor Jimenez-Yuste, Professor E. Carlos RODRIGUEZ-MERCHAN

  23. Effects of thrombopoietin receptor agonists on procoagulant state in patients with immune thrombocytopenia

    Article • Thrombosis and Haemostasis, February 2014, Schattauer GmbH

    Dr Victor Jimenez-Yuste

  24. Effects of thrombopoietin receptor agonists on procoagulant state in patients with immune thrombocytopenia

    Article • Thrombosis and Haemostasis, February 2014, Schattauer GmbH

    Dr Victor Jimenez-Yuste

  25. Valoración de la eficacia percibida de la dinamica grupal “¿qué-tal?” Para el autocuidado y aprendizaje mutuo en un equipo asistencial

    Article • Psicooncología, January 2014, Universidad Complutense de Madrid (UCM)

    Dr Victor Jimenez-Yuste

  26. Joint aspiration of acute tense knee haemarthroses in adult haemophilia A patients

    Article • Thrombosis Research, December 2013, Elsevier

    Dr Victor Jimenez-Yuste, Professor E. Carlos RODRIGUEZ-MERCHAN

  27. Primary and rescue immune tolerance induction in children and adults: a multicentre international study with a VWF ‐containing plasma‐derived FVIII concentrate

    Article • Haemophilia, November 2013, Wiley

    Dr Victor Jimenez-Yuste

  28. Severe postoperative haemarthrosis following a total knee replacement in a haemophiliac patient caused by a pseudoaneurysm: early treatment with arterial embolization

    Article • Haemophilia, October 2013, Wiley

    Dr Victor Jimenez-Yuste

  29. Rotational thromboelastometry (ROTEM) in Behçet's disease

    Article • Clinical Rheumatology, September 2013, Springer Science + Business Media

    Dr Victor Jimenez-Yuste

  30. Femur fracture in a woman with severe factor X deficiency - an experience using factor X concentrate in surgery

    Article • Haemophilia, August 2013, Wiley

    Dr Victor Jimenez-Yuste

  31. Factor VIII gene (F8) mutation and risk of inhibitor development in nonsevere hemophilia A

    Article • Blood, August 2013, American Society of Hematology

    Dr Victor Jimenez-Yuste

  32. Radiosynovectomy

    Article • Blood Coagulation & Fibrinolysis, July 2013, Wolters Kluwer Health

    Dr Victor Jimenez-Yuste

  33. Cost-effectiveness of recombinant activated factor VII vs. plasma-derived activated prothrombin complex concentrate in the treatment of mild-to-moderate bleeding episodes in patients with severe haemophilia A and inhibitors in Spain

    Article • Haemophilia, June 2013, Wiley

    Dr Victor Jimenez-Yuste

  34. 2013. Documento Sevilla de Consenso sobre Alternativas a la Transfusión de Sangre Alogénica. Actualización del Documento Sevilla

    Article • Medicina Intensiva, May 2013, Elsevier

    Dr Victor Jimenez-Yuste

  35. 2013. Documento Sevilla de Consenso sobre Alternativas a la Transfusión de Sangre Alogénica. Actualización del Documento Sevilla

    Article • Revista Española de Anestesiología y Reanimación, May 2013, Elsevier

    Dr Victor Jimenez-Yuste

  36. Platelet apoptosis and agonist-mediated activation in myelodysplastic syndromes

    Article • Thrombosis and Haemostasis, February 2013, Schattauer GmbH

    Dr Victor Jimenez-Yuste

  37. Novel coagulation factor concentrates: Issues relating to their clinical implementation and pharmacokinetic assessment for optimal prophylaxis in haemophilia patients

    Article • Haemophilia, February 2013, Wiley

    Dr Victor Jimenez-Yuste, Dr. Eduardo Remor

  38. Third Åland islands conference on von Willebrand disease, 26-28 September 2012: meeting report

    Article • Haemophilia, February 2013, Wiley

    Dr Victor Jimenez-Yuste

  39. Behçet’s disease: new insight into the relationship between procoagulant state, endothelial activation/damage and disease activity

    Article • Orphanet Journal of Rare Diseases, January 2013, Springer Science + Business Media

    Dr Victor Jimenez-Yuste, IHOSVANY FERNANDEZ BELLO

  40. Effective prophylaxis with rFVIIa in young haemophiliacs with inhibitors using a schedule similar to FVIII prophylaxis in non-inhibitor patients

    Article • Health, January 2013, Scientific Research Publishing, Inc,

    Dr Victor Jimenez-Yuste

  41. PRO-PACT: Retrospective observational study on the prophylactic use of recombinant factor VIIa in hemophilia patients with inhibitors

    Article • Thrombosis Research, December 2012, Elsevier

    Dr Victor Jimenez-Yuste

  42. Efficacy of factor IX Grifols® in surgery: experience of an international multicentre retrospective study

    Article • Haemophilia, July 2012, Wiley

    Dr Victor Jimenez-Yuste

  43. Management of delivery with FVIII/VWF concentrates in a pregnant woman with type 3 von Willebrand disease and alloantibodies

    Article • Thrombosis and Haemostasis, July 2012, Schattauer GmbH

    Dr Victor Jimenez-Yuste

  44. Optimizing joint function: new knowledge and novel tools and treatments

    Article • Haemophilia, July 2012, Wiley

    Dr Victor Jimenez-Yuste

  45. An uncommon cause of elbow synovitis in an adult haemophilia patient

    Article • Blood Coagulation & Fibrinolysis, July 2012, Wolters Kluwer Health

    Dr Victor Jimenez-Yuste

  46. F8 gene dosage defects in atypical patients with severe haemophilia A

    Article • Haemophilia, May 2012, Wiley

    Dr Victor Jimenez-Yuste

  47. A complex case of infected total knee arthroplasty in a haemophilic patient with inhibitor

    Article • Haemophilia, April 2012, Wiley

    Dr Victor Jimenez-Yuste

  48. Is on-demand treatment effective in patients with severe haemophilia?

    Article • Haemophilia, April 2012, Wiley

    Dr Victor Jimenez-Yuste

  49. Iatrogenic fracture of the proximal tibia as a complication of knee manipulation under anaesthesia in a haemophilia patient with an ipsilateral stiff knee secondary to a supracondylar non-union of the femur

    Article • Haemophilia, April 2012, Wiley

    Dr Victor Jimenez-Yuste

  50. Management of bleeding disorders in adults

    Article • Haemophilia, April 2012, Wiley

    Dr Victor Jimenez-Yuste

  51. Platelet soluble CD40L and matrix metalloproteinase 9 activity are proinflammatory mediators in Behçet disease patients

    Article • Thrombosis and Haemostasis, November 2011, Schattauer GmbH

    Dr Victor Jimenez-Yuste

  52. Pharmacokinetic properties of two different recombinant activated factor VII formulations

    Article • Haemophilia, October 2011, Wiley

    Dr Victor Jimenez-Yuste

  53. Liver transplantation in Spanish haemophiliacs

    Article • Haemophilia, September 2011, Wiley

    Dr Victor Jimenez-Yuste

  54. Joint protection in haemophilia

    Article • Haemophilia, August 2011, Wiley

    Dr Victor Jimenez-Yuste

  55. Late avascular necrosis of the femoral head (anfh) after the percutaneous fixation of a non-displaced fracture of the femoral neck in a haemophilic patient with inhibitors: a non-reported association

    Article • Haemophilia, July 2011, Wiley

    Dr Victor Jimenez-Yuste

  56. An uncommon cause of knee haemarthrosis in an adult haemophilia patient suffering from long-term paraplegia

    Article • Haemophilia, June 2011, Wiley

    Dr Victor Jimenez-Yuste

  57. Prophylaxis in Adults with Hemophilia

    Article • May 2011, Wiley

    Dr Victor Jimenez-Yuste

  58. Initial and Advanced Stages of Hemophilic Arthropathy, and Other Musculo-Skeletal Problems: The Role of Orthopedic Surgery

    Article • May 2011, Wiley

    Dr Victor Jimenez-Yuste

  59. Current and Future Approaches to Gene Therapy in Patients with Hemophilia

    Article • May 2011, Wiley

    Dr Victor Jimenez-Yuste

  60. Radiosynovectomy in hemophilia: quantification of its effectiveness through the assessment of 10 articular parameters

    Article • Journal of Thrombosis and Haemostasis, May 2011, Wiley

    Dr Victor Jimenez-Yuste

  61. Radiosynovectomy in patients with chronic haemophilic synovitis: when is more than one injection necessary?

    Article • European Journal Of Haematology, April 2011, Wiley

    Dr Victor Jimenez-Yuste

  62. Infection after total knee arthroplasty in haemophilic arthropathy with special emphasis on late infection

    Article • Haemophilia, April 2011, Wiley

    Dr Victor Jimenez-Yuste

  63. What patient, joint and isotope characteristics influence the response to radiosynovectomy in patients with haemophilia?

    Article • Haemophilia, April 2011, Wiley

    Dr Victor Jimenez-Yuste

  64. When should prophylaxis therapy in inhibitor patients be considered?

    Article • Haemophilia, March 2011, Wiley

    Dr Victor Jimenez-Yuste

  65. Focusing on haemophilia B: prophylaxis in Spanish patients

    Article • Haemophilia, November 2010, Wiley

    Dr Victor Jimenez-Yuste

  66. Prophylaxis therapy in haemophilia A: current situation in Spain

    Article • Haemophilia, November 2010, Wiley

    Dr Victor Jimenez-Yuste, Dr Nuria Bermejo

  67. Improving Type 1 Diabetes After Treatment of Immune Thrombocytopenia With Rituximab: Killing Two Birds With One Stone

    Article • Diabetes Care, August 2010, American Diabetes Association

    Dr Victor Jimenez-Yuste

  68. Clinical and genetic findings in five female patients with haemophilia A: Identification of a novel missense mutation, p.Phe2127Ser

    Article • Thrombosis and Haemostasis, July 2010, Schattauer GmbH

    Dr Victor Jimenez-Yuste

  69. Paediatric haemophilia with inhibitors: existing management options, treatment gaps and unmet needs

    Article • Haemophilia, September 2009, Wiley

    Dr Victor Jimenez-Yuste

  70. Possible role for cellular FXIII in monocyte-derived dendritic cell motility

    Article • European Journal of Cell Biology, August 2009, Elsevier

    Dr Victor Jimenez-Yuste

  71. The role of selective angiographic embolization of the musculo-skeletal system in haemophilia

    Article • Haemophilia, July 2009, Wiley

    Dr Victor Jimenez-Yuste

  72. New insights into the expression and role of platelet factor XIII-A

    Article • Journal of Thrombosis and Haemostasis, July 2009, Wiley

    Dr Victor Jimenez-Yuste

  73. Haemophilia in Spain

    Article • Haemophilia, May 2009, Wiley

    Dr Victor Jimenez-Yuste

  74. Surgery in haemophilia patients with inhibitors, with special emphasis on orthopaedics: Madrid experience

    Article • Haemophilia, February 2009, Wiley

    Dr Victor Jimenez-Yuste

  75. Prophylaxis in 10 patients with severe haemophilia A and inhibitor: different approaches for different clinical situations

    Article • Haemophilia, January 2009, Wiley

    Dr Victor Jimenez-Yuste

  76. Review: Factor XI Deficiency: Review and Management in Pregnant Women

    Article • Clinical and Applied Thrombosis/Hemostasis, December 2008, SAGE Publications

    Dr Victor Jimenez-Yuste

  77. Orthopaedic surgery in haemophilia patients with inhibitors as the last resort

    Article • Haemophilia, November 2008, Wiley

    Dr Victor Jimenez-Yuste

  78. Experiences in the prevention of arthropathy in haemophila patients with inhibitors

    Article • Haemophilia, November 2008, Wiley

    Dr Victor Jimenez-Yuste

  79. Prevention of haemophilic arthropathy during childhood. May common orthopaedic management be extrapolated from patients without inhibitors to patients with inhibitors?

    Article • Haemophilia, November 2008, Wiley

    Dr Victor Jimenez-Yuste

  80. “Primary prophylaxis” with rFVIIa in a patient with severe haemophilia a and inhibitor

    Article • Blood Coagulation & Fibrinolysis, October 2008, Wolters Kluwer Health

    Dr Victor Jimenez-Yuste

  81. Clinical efficacy in bleeding and surgery in von Willebrand patients treated with Fanhdi®a highly purified, doubly inactivated FVIII/VWF concentrate

    Article • Haemophilia, September 2008, Wiley

    Dr Victor Jimenez-Yuste

  82. Acquired von Willebrand syndrome

    Article • Haemophilia, July 2008, Wiley

    Dr Victor Jimenez-Yuste

  83. Controversies and Challenges in Elective Orthopedic Surgery in Patients With Hemophilia and Inhibitors

    Article • Seminars in Hematology, April 2008, Elsevier

    Dr Victor Jimenez-Yuste

  84. Management of the Delivery in Pregnant Women with Severe Factor XI Deficiency

    Article • Acta Haematologica, January 2008, Karger Publishers

    Dr Victor Jimenez-Yuste

  85. Haemoperitoneum in a female patient with haemophilia A caused by a ruptured ovarian follicle

    Article • Haemophilia, November 2007, Wiley

    Dr Victor Jimenez-Yuste

  86. Orthopaedic surgery for inhibitor patients: a series of 27 procedures (25 patients)

    Article • Haemophilia, September 2007, Wiley

    Dr Victor Jimenez-Yuste

  87. Rituximab in the management of chronic immune thrombocytopenic purpura: an effective and safe therapeutic alternative in refractory patients

    Article • Annals of Hematology, May 2006, Springer Science + Business Media

    Dr Victor Jimenez-Yuste

  88. Rituximab in the management of chronic immune thrombocytopenic purpura: an effective and safe therapeutic alternative in refractory patients

    Article • Annals of Hematology, March 2006, Springer Science + Business Media

    Dr Victor Jimenez-Yuste

  89. Psychometric field study of the new haemophilia quality of life questionnaire for adults: The 'Hemofilia-QoL'

    Article • Haemophilia, November 2005, Wiley

    Dr Victor Jimenez-Yuste, Dr. Eduardo Remor

  90. Prophylactic treatment effects on inhibitor risk: experience in one centre

    Article • Haemophilia, March 2005, Wiley

    Dr Victor Jimenez-Yuste

  91. Surgery in haemophilic patients with inhibitor: 20 years of experience

    Article • Haemophilia, September 2004, Wiley

    Dr Victor Jimenez-Yuste

  92. Acquired Haemophilia: Review and Meta-Analysis Focused on Therapy and Prognostic Factors

    Article • British Journal of Haematology, April 2003, Wiley

    Dr Victor Jimenez-Yuste

  93. Analysis of the causes of immediate unanticipated bleeding after pediatric adenotonsillectomy

    Article • International Journal of Pediatric Otorhinolaryngology, April 2003, Elsevier

    Dr Victor Jimenez-Yuste

  94. Otolaryngologic Surgery in Children With von Willebrand Disease

    Article • Archives of Otolaryngology - Head and Neck Surgery, December 2002, American Medical Association (AMA)

    Dr Victor Jimenez-Yuste

  95. Acquired hemophilia: a single-center survey with emphasis on immunotherapy and treatment-related side-effects

    Article • European Journal Of Haematology, September 2002, Wiley

    Dr Victor Jimenez-Yuste

  96. Successful thyroidectomy in a patient with Hermansky–Pudlak syndrome treated with recombinant activated factor VII and platelet concentrates

    Article • Blood Coagulation & Fibrinolysis, September 2002, Wolters Kluwer Health

    Dr Victor Jimenez-Yuste

  97. Induction of a Hypercoagulability State and Endothelial Cell Activation by Granulocyte Colony-Stimulating Factor in Peripheral Blood Stem Cell Donors

    Article • Journal of Hematotherapy & Stem Cell Research, August 2002, Mary Ann Liebert Inc

    Dr Victor Jimenez-Yuste

  98. The use of haemostatic drugs in haemophilia: desmopressin and antifibrinolytic agents

    Article • Haemophilia, May 2002, Wiley

    Dr Victor Jimenez-Yuste

  99. Complications of central venous catheters in patients with haemophilia and inhibitors

    Article • Haemophilia, November 2001, Wiley

    Dr Victor Jimenez-Yuste

  100. Yttrium-90 synoviorthesis for chronic haemophilic synovitis: Madrid experience

    Article • Haemophilia, July 2001, Wiley

    Dr Victor Jimenez-Yuste

  101. Continuous infusion of recombinant activated factor VII during caesarean section delivery in a patient with congenital factor VII deficiency

    Article • Haemophilia, September 2000, Wiley

    Dr Victor Jimenez-Yuste

  102. A prospective randomized trial of granulocyte colony-stimulating factor therapy after autologous blood stem cell transplantation in adults

    Article • Bone Marrow Transplantation, September 1999, Springer Science + Business Media

    Dr Victor Jimenez-Yuste

  103. Erratum: Case report: Haploidentical peripheral blood stem cell transplantation with a combination of CD34 selection and T cell depletion as graft-versus-host disease prophylaxis in a patient with severe combined immunodeficiency

    Article • Bone Marrow Transplantation, March 1998, Springer Science + Business Media

    Dr Victor Jimenez-Yuste

  104. Hematopoietic cell transplantation using plasma and DMSO without HES, with non-programmed freezing by immersion in a methanol bath: results in 213 cases

    Article • Bone Marrow Transplantation, March 1998, Springer Science + Business Media

    Dr Victor Jimenez-Yuste

  105. Haploidentical peripheral blood stem cell transplantation with a combination of CD34 selection and T cell depletion as graft-versus-host disease prophylaxis in a patient with severe combined immunodeficiency

    Article • Bone Marrow Transplantation, November 1997, Springer Science + Business Media

    Dr Victor Jimenez-Yuste

  106. Haemophilia A and chronic hepatopathy caused by extrahepatic biliary atresia: two congenital diseases cured by orthotopic liver transplantation

    Article • Haemophilia, April 1997, Wiley

    Dr Victor Jimenez-Yuste

  107. Posttransplant CD30 (Ki-1)–Positive Anaplastic Large Cell Lymphoma

    Article • Acta Cytologica, January 1997, Karger Publishers

    Dr Victor Jimenez-Yuste

  108. Osteonecrosis of the Femoral Head

    Article • Wiley

    Dr Victor Jimenez-Yuste

  109. Haematological Substitutive Treatment of Haemophilic Haemarthroses

    Article • Wiley

    Dr Victor Jimenez-Yuste

  110. General Medical Management of Bleeding Episodes: Haemarthroses, Muscle Haematomas, Mucocutaneous Bleeding and Haematuria

    Article • Wiley

    Dr Victor Jimenez-Yuste